Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Pain (Neuropathic) (Duloxetine - Pain (Neuropathic))

Records returned : 14 (on 29 May 2025 at 13:20:07). Return to search results for ' Pain (Neuropathic) '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Duloxetine

Drug:

Duloxetine

Indication :

Pain (Neuropathic)

Status :

Green

Formulations :

Capsules

Restrictions / Comments:

Important

Licensed only for diabetic peripheral neuropathic pain but also recommended as per NICE CG173 (off- label indication) as a treatment option in neuropathic pain.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Amitriptyline hydrochloride

Drug:

Amitriptyline hydrochloride

Indication :

Pain (Neuropathic)

Status :

Green

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Gabapentin

Drug:

Gabapentin

Indication :

Pain (Neuropathic)

Status :

Green

Formulations :

Capsules
Oral solution
Tablets

Restrictions / Comments:

Important

First line gabapentinoid.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NICE

4. Capsaicin

Drug:

Capsaicin

Indication :

Pain (Neuropathic)

Status :

Green (see narrative)

Formulations :

Cream

Restrictions / Comments:

Important

For patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine)

0.075% cream (Axsain brand) is licensed for this indication

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NICE

9. Capsaicin

Drug:

Capsaicin

Indication :

Pain (Neuropathic)

Status :

Red

Formulations :

Patches

Restrictions / Comments:

Important

For patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine)

To be initiated by specialist pain care teams only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Pregabalin

Drug:

Pregabalin

Indication :

Pain (Neuropathic)

Status :

Green (see narrative)

Formulations :

Capsules

Restrictions / Comments:

Important

Gabapentin is preferred due to lower potential for misuse. Pregabalin capsules more cost effective than tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Pregabalin

Drug:

Pregabalin

Indication :

Pain (Neuropathic)

Status :

Green (see narrative)

Formulations :

Oral solution

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

14. Pregabalin

Drug:

Pregabalin

Indication :

Pain (Neuropathic)

Status :

Non Formulary

Formulations :

Modified release tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD2

7. Tramadol hydrochloride

Drug:

Tramadol hydrochloride

Indication :

Pain (Neuropathic)

Status :

Green (see narrative)

Formulations :

Capsules
Soluble tablets

Restrictions / Comments:

Important

NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. Tramadol hydrochloride

Drug:

Tramadol hydrochloride

Indication :

Pain (Neuropathic)

Status :

Green (see narrative)

Formulations :

Modified release capsules
Modified release tablets

Restrictions / Comments:

Important

NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.

MR preparations to be prescribed by brand. Marol MR tablets are the locally preferred brand for primary care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP